The agency has issued draft guidance on opioid prescribing. It’s an improvement over a 2016 version that left too many patients in pain—but the director needs to make it even better.
The agency has issued draft guidance on opioid prescribing. It’s an improvement over a 2016 version that left too many patients in pain—but the director needs to make it even better.